NIH-funded research R01 grant

Understanding how lung cells regenerate after injury

Official title: Control of lung alveolar regeneration by Dot1L/H3K79 methylation

Funded at University of Pennsylvania · NIH-11018540 · Data updated 2026-11-12

This study is looking at how certain lung cells can help heal damaged lungs, which could lead to better treatments for people with lung injuries or chronic lung diseases.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startFebruary 1, 2023
Project endJanuary 31, 2027
Funding year2025
Award (this year)$512,593
NIH project number5R01HL162683-03
Project IDNIH-11018540 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced acute lung injuries or have chronic lung conditions affecting their alveoli.

Less likely to help

Patients with stable lung conditions that do not involve acute injury or significant regeneration needs may not benefit from this research.

What this research studies

This research investigates the mechanisms behind the regeneration of lung alveoli, which are essential for breathing and responding to environmental threats. It focuses on a specific type of lung cell, the alveolar type 2 (AT2) cell, which can transform into another type of cell to help repair damaged lung tissue. By using advanced techniques, including small molecule screening and organoid assays, the study aims to identify pathways that enhance the repair process in the lungs. This could lead to new treatments for patients suffering from acute lung injuries or chronic lung diseases.

Why it matters

Potential benefit: If successful, this research could lead to innovative therapies that improve lung healing and function in patients with acute lung injuries.

How similar studies have gone: Previous research has shown promise in understanding lung cell regeneration, but this specific approach focusing on Dot1L and H3K79 methylation is relatively novel.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Morrisey, Edward E — University of Pennsylvania
  • Study coordinator: Morrisey, Edward E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.